Discuss moderation, risks, and personalized strategies rather than mandate abstinence unless medically indicated
Manufacturer savings programs Eli Lilly has not yet launched retatrutide commercially, so no manufacturer savings program currently exists
CrossRef Association Between Metabolically Associated Steatotic Liver Disease (MASLD) and Cardiovascular Risk Scores in Urban Adults FARIS HUSSAIN, KELVIN KANAYO NWABUEZE, FATIMA IJAZ, SONIA OUTALEB, MAHMUDUL HASAN NAHID, SYED ABID, MARIAM SALEEM, KHANT NYI ZAYA, SAIFULLAH SYED, HUMAIRA JANANTH, MANAHIL ZARIEF Juntendo Medical Journal .2026
Additional tirzepatide safety concerns include risk of acute gallbladder disease (presenting as right upper quadrant pain, fever, or jaundice), acute kidney injury from dehydration (especially if severe gastrointestinal symptoms occur), and hypersensitivity reactions
Severe gastroparesis is another major concern because both products are not recommended in patients with this condition